vs
Industrial Logistics Properties Trust（ILPT）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Industrial Logistics Properties Trust的1.1倍（$127.1M vs $113.9M），再鼎医药同比增速更快（17.1% vs 3.1%），Industrial Logistics Properties Trust自由现金流更多（$42.0M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 0.7%）
Industrial Logistics Properties Trust是一家专注于工业与物流地产的房地产投资信托，主要在美国境内持有及运营配送中心、仓储设施与最后一公里配送物业，为电商、零售、制造及供应链运营企业提供仓储及物流运营相关配套服务。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
ILPT vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.1倍
$113.9M
营收增速更快
ZLAB
高出14.1%
3.1%
自由现金流更多
ILPT
多$68.7M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $113.9M | $127.1M |
| 净利润 | $-1.8M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | -22.1% | -54.6% |
| 净利率 | -1.6% | — |
| 营收同比 | 3.1% | 17.1% |
| 净利润同比 | 92.6% | — |
| 每股收益（稀释后） | $-0.02 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ILPTZLAB
| Q4 25 | $113.9M | $127.1M | ||
| Q3 25 | $110.9M | $115.4M | ||
| Q2 25 | $112.1M | $109.1M | ||
| Q1 25 | $111.9M | $105.7M | ||
| Q4 24 | $110.5M | $108.5M | ||
| Q3 24 | $108.9M | $101.8M | ||
| Q2 24 | $110.6M | $100.1M | ||
| Q1 24 | $112.2M | $87.1M |
净利润ILPTZLAB
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-21.6M | $-36.0M | ||
| Q2 25 | $-21.3M | $-40.7M | ||
| Q1 25 | $-21.5M | $-48.4M | ||
| Q4 24 | $-24.1M | — | ||
| Q3 24 | $-25.0M | $-41.7M | ||
| Q2 24 | $-23.2M | $-80.3M | ||
| Q1 24 | $-23.4M | $-53.5M |
毛利率ILPTZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率ILPTZLAB
| Q4 25 | -22.1% | -54.6% | ||
| Q3 25 | -29.4% | -42.3% | ||
| Q2 25 | -30.8% | -50.3% | ||
| Q1 25 | -26.9% | -53.3% | ||
| Q4 24 | -31.1% | -62.6% | ||
| Q3 24 | -33.5% | -66.6% | ||
| Q2 24 | -32.4% | -76.0% | ||
| Q1 24 | -31.7% | -80.7% |
净利率ILPTZLAB
| Q4 25 | -1.6% | — | ||
| Q3 25 | -19.4% | -31.2% | ||
| Q2 25 | -19.0% | -37.3% | ||
| Q1 25 | -19.2% | -45.8% | ||
| Q4 24 | -21.8% | — | ||
| Q3 24 | -22.9% | -40.9% | ||
| Q2 24 | -20.9% | -80.2% | ||
| Q1 24 | -20.9% | -61.4% |
每股收益（稀释后）ILPTZLAB
| Q4 25 | $-0.02 | $-0.05 | ||
| Q3 25 | $-0.33 | $-0.03 | ||
| Q2 25 | $-0.32 | $-0.04 | ||
| Q1 25 | $-0.33 | $-0.04 | ||
| Q4 24 | $-0.37 | $-0.09 | ||
| Q3 24 | $-0.38 | $-0.04 | ||
| Q2 24 | $-0.35 | $-0.08 | ||
| Q1 24 | $-0.36 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $94.8M | $689.6M |
| 总债务越低越好 | $4.2B | — |
| 股东权益账面价值 | $489.7M | $715.5M |
| 总资产 | $5.2B | $1.2B |
| 负债/权益比越低杠杆越低 | 8.56× | — |
8季度趋势，按日历期对齐
现金及短期投资ILPTZLAB
| Q4 25 | $94.8M | $689.6M | ||
| Q3 25 | $83.2M | $717.2M | ||
| Q2 25 | $58.6M | $732.2M | ||
| Q1 25 | $108.0M | $757.3M | ||
| Q4 24 | $131.7M | $779.7M | ||
| Q3 24 | $153.9M | $616.1M | ||
| Q2 24 | $146.2M | $630.0M | ||
| Q1 24 | $128.4M | $650.8M |
总债务ILPTZLAB
| Q4 25 | $4.2B | — | ||
| Q3 25 | $4.2B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.3B | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.3B | — |
股东权益ILPTZLAB
| Q4 25 | $489.7M | $715.5M | ||
| Q3 25 | $494.1M | $759.9M | ||
| Q2 25 | $519.1M | $791.7M | ||
| Q1 25 | $539.5M | $810.8M | ||
| Q4 24 | $562.0M | $840.9M | ||
| Q3 24 | $585.9M | $667.7M | ||
| Q2 24 | $618.3M | $704.2M | ||
| Q1 24 | $643.2M | $762.2M |
总资产ILPTZLAB
| Q4 25 | $5.2B | $1.2B | ||
| Q3 25 | $5.2B | $1.2B | ||
| Q2 25 | $5.2B | $1.2B | ||
| Q1 25 | $5.4B | $1.2B | ||
| Q4 24 | $5.4B | $1.2B | ||
| Q3 24 | $5.5B | $985.3M | ||
| Q2 24 | $5.5B | $987.4M | ||
| Q1 24 | $5.5B | $988.4M |
负债/权益比ILPTZLAB
| Q4 25 | 8.56× | — | ||
| Q3 25 | 8.49× | — | ||
| Q2 25 | 8.09× | — | ||
| Q1 25 | 7.96× | — | ||
| Q4 24 | 7.65× | — | ||
| Q3 24 | 7.35× | — | ||
| Q2 24 | 6.96× | — | ||
| Q1 24 | 6.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.7M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $42.0M | $-26.7M |
| 自由现金流率自由现金流/营收 | 36.9% | -21.0% |
| 资本支出强度资本支出/营收 | 16.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $79.8M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流ILPTZLAB
| Q4 25 | $60.7M | $-26.0M | ||
| Q3 25 | $22.7M | $-32.0M | ||
| Q2 25 | $18.4M | $-31.0M | ||
| Q1 25 | $11.4M | $-61.7M | ||
| Q4 24 | $2.0M | $-55.8M | ||
| Q3 24 | $-3.4M | $-26.8M | ||
| Q2 24 | $10.8M | $-42.2M | ||
| Q1 24 | $8.0M | $-90.1M |
自由现金流ILPTZLAB
| Q4 25 | $42.0M | $-26.7M | ||
| Q3 25 | $17.6M | $-35.0M | ||
| Q2 25 | $15.2M | $-33.9M | ||
| Q1 25 | $5.0M | $-63.2M | ||
| Q4 24 | $-3.7M | $-58.4M | ||
| Q3 24 | $-5.9M | $-28.2M | ||
| Q2 24 | $9.4M | $-42.9M | ||
| Q1 24 | $5.9M | $-91.1M |
自由现金流率ILPTZLAB
| Q4 25 | 36.9% | -21.0% | ||
| Q3 25 | 15.9% | -30.4% | ||
| Q2 25 | 13.5% | -31.1% | ||
| Q1 25 | 4.5% | -59.9% | ||
| Q4 24 | -3.4% | -53.8% | ||
| Q3 24 | -5.5% | -27.7% | ||
| Q2 24 | 8.5% | -42.9% | ||
| Q1 24 | 5.2% | -104.5% |
资本支出强度ILPTZLAB
| Q4 25 | 16.4% | 0.5% | ||
| Q3 25 | 4.6% | 2.6% | ||
| Q2 25 | 2.9% | 2.6% | ||
| Q1 25 | 5.7% | 1.5% | ||
| Q4 24 | 5.2% | 2.4% | ||
| Q3 24 | 2.3% | 1.3% | ||
| Q2 24 | 1.3% | 0.7% | ||
| Q1 24 | 1.9% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ILPT
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
